According to the latest report by IMARC Group, title “Hydrocephalus Shunts Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, the global hydrocephalus shunts market reached a value of US$ 412.6 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 540.4 Million by 2027 exhibiting a CAGR of 4.20% during 2022-2027.
Request for a Free Sample Copy of This Report: https://www.imarcgroup.com/hydrocephalus-shunts-market/requestsample
Hydrocephalus Shunts Industry Outlook:
Hydrocephalus shunts are medical devices used to treat a condition that occurs when cerebrospinal fluid (CSF) builds up in the ventricles of the brain. They are commonly available in catheters, adjustable pressure valves, and fixed pressure valve variants. These devices comprise an inflow or proximal catheter that drains CSF from the lateral ventricles, a valve mechanism that regulates intracranial pressure by controlling fluid flow, and an outflow or distal catheter that runs under the skin and directs CSF. In addition, they are placed into the brain to relieve the tension on the cerebrum that returns the brain’s enlarged ventricles to their actual size. Owing to these properties, hydrocephalus shunts are widely adopted across the healthcare sector.
The market is primarily driven by the increasing prevalence of brain and neurological disorders among individuals, especially the geriatric population. Hydrocephalus shunts are extensively used due to the rising occurrence of congenital abnormalities, brain and nerve injuries, accidents leading to central nervous system (CNS) defects, and lifestyle diseases.
In addition, the escalating product demand to treat hydrocephalus among infants that could lead to enlargement of the head and damage to the brain represents another significant growth-inducing factor. Moreover, various technological advancements, including the development of anti-siphon devices that assist in avoiding siphon effects over cerebrospinal fluid and programmable valves for controlling the flow of cerebrospinal fluid to prevent it from moving in the wrong direction are providing a positive thrust to market growth.
Furthermore, the developing healthcare industry and the implementation of various government initiatives to spread awareness regarding hydrocephalus shunts are anticipated to propel market growth.
Read Full Report with Table of Contents: https://bit.ly/3wOI56j
|Hydrocephalus Shunts Market Report Scope|
|Market size value in 2021||US$ 412.6 Million|
|Market forecast in 2027||US$ 540.4 Million|
|Growth Rate||CAGR of 4.20% from 2022 to 2027|
|Base year for estimation||2021|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Segments covered||Type, Product Type, Age Group, End User and Region|
|Market Dynamics||Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,|
|Customization preview||If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.|
Key Market Segmentation:
The report has been segmented the market into following categories:
Breakup by Type:
Breakup by Product Type:
- Hydrocephalus Valves
- Adjustable Pressure Valves
- Fix Pressure Valves
- Hydrocephalus Catheters
Breakup by Age Group:
Breakup by End User:
- Ambulatory Surgical Centers
Breakup by Geography:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=reportid=5226flag=C
List of Key Companies Covered in this Market Report:
The major players in the market are Argi Group, B. Braun Melsungen AG, Christoph Miethke GmbH Co. KG, G. Surgiwear Ltd., HLL Lifecare Limited, Integra LifeSciences, Kaneka Medix Corporation (Kaneka Corporation), Medtronic Plc, Natus Medical Incorporated, Sophysa, Spiegelberg GmbH Co. KG (SHS Medizintechnik Holding GmbH) and TKB Corporation.
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
About IMARC Group:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Company Name: IMARC Group
Contact Person: Elena Anderson
Address: 30 N Gould St Ste R
Country: United States